https://www.aidsmap.com/news/nov-2013/daclatasvir-asunaprevir-cures-85-genotype-1b-hepatitis-c-patients-japanese-study
An interferon- and ribavirin-free oral regimen of daclatasvir plus asunaprevir taken for 24 weeks led to sustained virological response (SVR12) in 85% of...
hepatitis cdaclatasvirasunaprevircuresgenotype